Intellectual property

Depending who you ask, the long-awaited and final ruling on the University of Wisconsin’s WARF patent is either a landmark decision or signifies nothing.

The Commission and the European Patent office are taking action to eradicate underhand tactics for keeping generic drugs off the market.

US genomics firm Myriad Genetics regains limited rights to BRCA1 breast cancer gene on final appeal.

Austrian MEP Paul Rübig received the European Patent Office’s 2008 award for Research & Innovation in recognition of his strong advocacy for small and medium-sized enterprises.

The US and European patent offices have launched a trial of the Patent Prosecution Highway, a scheme they say will speed up the granting of patents.

Bosch, DuPont and Xerox Corporation have joined a business-inspired movement to put environmentally important IP into the public domain.

After frowning on the idea of avoiding patent litigation through arbitration, the European Commission appears to have changed its mind.

Just under a year since the last suit was settled Bavarian Nordic is going back to court, seeking a slice of a lucrative cancer vaccine deal.

Two days were reserved by the European Patent Office to hear an appeal over the application for a stem cell patent. But only one was needed in the end.

Supreme Court Rulings and patent reform are making it harder to defend patents in the US – and biotechs are falling back on trade secrets to protect their IP.